v3.26.1
STOCKHOLDERS’ EQUITY (Tables)
 12 Months Ended
Dec. 31, 2025
Accumulated Other Comprehensive Income (Loss) [Line Items]  
SCHEDULE OF RESERVED SHARES

 

     
Exercise of issued and future grants of stock options   13,544 
Conversion of Series A-2 preferred stock   267,364 
Conversion of Series B preferred stock   17,784,061 
Conversion of convertible debt   58,771 
Exercise of stock warrants   1,226,648 
Total   19,350,388 
SCHEDULE OF OUTSTANDING PREFERRED STOCK

 

   Authorized Shares   Outstanding Shares   Conversion Price   Common Stock Equivalent 
Series A-2   10,000    601   $2.246    267,364 
Series B   500,000    39,943   $2.246    17,784,061 
SCHEDULE OF STOCK OPTION ACTIVITY

The following represents a summary of the options granted to employees and non-employee service providers that were outstanding at December 31, 2025, and changes during the twelve-months then ended:

 

   Shares   Weighted–
Average
Exercise
Price		   Range of
Exercise
Price		   Weighted–
Average
Remaining
Life (Years)		 
Total outstanding – December 31, 2024   1,870   $1,948.41   $256.80 — $2,565.00    5.93 
Granted   —    —    —    — 
Expired   —    —    —    — 
Forfeited   (300)  $1,527.27   $256.80 — $2,565.00    — 
Total outstanding – December 31 , 2025   1,570   $2,028.88   $256.80 — $2,485.00    4.86 
Exercisable (vested)   1,570   $2,028.88   $256.80 — $2,485.00    4.86 
Non-Exercisable (non-vested)   —    —    —    — 

 

 

The following represents a summary of the options granted to employees and non-employee service providers that were outstanding at December 31, 2024, and changes during the twelve months then ended:

 

       Weighted–       Weighted– 
       Average   Range of   Average 
       Exercise   Exercise   Remaining 
   Shares   Price   Price   Life (Years) 
Total outstanding – December 31, 2023   7,978   $1,760.26   $256.80 — $2,565.00    7.06 
Granted   —    —    —    — 
Expired   —    —    —    — 
Forfeited   (6,108)  $1,703.64   $256.80 — $2,565.00    — 
Total outstanding – December 31, 2024   1,870   $1,948.41   $256.80 — $2,565.00    5.93 
Exercisable (vested)   1,714   $2,085.52   $256.80 — $2,565.00    5.81 
Non-Exercisable (non-vested)   156   $442.02   $256.80 — $620.00    7.24 
Compensatory Warrant Activity [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
SCHEDULE OF NON COMPENSATORY WARRANT ACTIVITY

The following table summarizes the equity classified compensatory warrant activity for the year ended December 31, 2025:

 

   Common Stock 
   Shares   Weighted–Average
Exercise
Price		   Range of
Exercise Price		   Weighted–
Average
Remaining
Life (Years)		 
Total outstanding – December 31, 2024   509   $1,270.25   $1,270.25 — $1,270.25    0.69 
Exercised   —    —    —    — 
Expired   (349)  $1,270.25   $1,270.25 — $1,270.25    — 
Reclassified to liabilities   (1,353)  $6.50    $6.50 — $6.50      
Forfeited   —    —    —    — 
Total outstanding – December 31, 2025   160   $1,270.25   $1,270.25— $1,270.25    0.81 
Exercisable   160   $1,270.25   $1,270.25 — $1,270.25    0.81 
Non-Exercisable   —    —    —    — 

 

 

The following table summarizes the equity classified compensatory warrant activity for the year ended December 31, 2024:

 

   Common Stock 
   Shares   Weighted–Average
Exercise
Price		   Range of
Exercise Price		   Weighted–
Average
Remaining
Life (Years)		 
Total outstanding – December 31, 2023   2,381   $534.44    $66.00 — $1,270.25    1.25 
Exercised   —    —    —    — 
Expired   (519)  $1,033.15    $1,033.15 — $1,033.15    — 
Reclassified to liabilities   (1,353)  $6.50    $6.50 — $6.50      
Forfeited   —    —    —    — 
Total outstanding – December 31, 2024   509   $1,270.25    $1,270.25 — $1,270.25    0.69 
Exercisable   509   $1,270.25    $1,270.25 — $1,270.25    0.69 
Non-Exercisable   —    —    —    — 
Non Compensatory Warrant Activity [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
SCHEDULE OF NON COMPENSATORY WARRANT ACTIVITY

The following table summarizes the noncompensatory equity classified warrant activity for the year ended December 31, 2025:

 

   Common Stock 
   Shares   Weighted–
Average
Exercise
Price		   Range of
Exercise Price		   Weighted–
Average
Remaining
Life (Years)		 
Total outstanding – December 31, 2024   72,004   $6.50   $6.50 — $6.50    3.99 
Granted   1,087,266   $2.47   $2.47 — $2.47    5.00 
Pre-funded investor warrants issued   239,456    0.05   $0.05 — $0.05    n/a 
Pre-funded investor warrants exercised   (188,257)   0.05   $0.05 — $0.05    n/a 
Exercised   —    —    —    — 
Reclassified to liabilities   (69,672)   2.06   $0.05 — $7.80    — 
Reclassified from liabilities   38,315    6.50   $6.50 — $6.50      
Expired   —    —    —    — 
Forfeited   —    —    —    — 
Total outstanding – December 31, 2025   1,159,270   $2.72   $2.47 — $6.50    4.64 
Exercisable   1,159,270   $2.72   $2.47 — $6.50     4.64 
Non-Exercisable   —    —    —    — 

 

The following table summarizes the noncompensatory equity classified warrant activity for the year ended December 31, 2024:

 

   Common Stock 
   Shares   Weighted–
Average
Exercise
Price		   Range of
Exercise Price		   Weighted–
Average
Remaining
Life (Years)		 
Total outstanding – December 31, 2023   50,141   $36.50   $36.50 — $36.50    4.47 
Granted   34,019    7.11   $6.50 — $7.80    4.16 
Pre-funded investor warrants issued   239,456    0.05   $0.05 — $0.05    n/a 
Pre-funded investor warrants exercised   (188,257)   0.05   $0.05 — $0.05    n/a 
Exercised   (31,998)   13.00   $13.00 — $13.00    — 
Reclassified to liabilities   (69,672)   2.06   $0.05 — $7.80    — 
Reclassified from liabilities   38,315    6.50   $6.50 — $6.50      
Expired   —    —    —    — 
Forfeited   —    —    —    — 
Total outstanding – December 31, 2024   72,004   $6.50   $6.50 — $6.50    — 
Exercisable   72,004   $6.50   $6.50 — $6.50    3.99 
Non-Exercisable   —    —    —    —